Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence

Title
Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
Authors
Keywords
Mild Cognitive Impairment, Liraglutide, Mild Cognitive Impairment Patient, Brain Insulin, Intranasal Insulin
Journal
CNS DRUGS
Volume 27, Issue 7, Pages 505-514
Publisher
Springer Nature
Online
2013-05-29
DOI
10.1007/s40263-013-0076-8

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started